SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-054169
Filing Date
2014-02-14
Accepted
2014-02-14 14:08:04
Documents
2
Group Members
AGECHEM FINANCIAL INC.ELIZABETH DOUVILLEINES HOLZBAURLOUIS LACASSEMARTIAL LACROIX

Document Format Files

Seq Description Document Type Size
1 SC 13G d675981dsc13g.htm SC 13G 148523
2 EX-99.A d675981dex99a.htm EX-99.A 7246
  Complete submission text file 0001193125-14-054169.txt   157437
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 14614526
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 WESTMOUNT SQUARE SUITE 800 MONTREAL A8 H3Z 2P9
Business Address 1 WESTMOUNT SQUARE SUITE 800 MONTREAL A8 H3Z 2P9 (514) 849-7994
AGECHEM VENTURE FUND L.P. (Filed by) CIK: 0001600156 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13G